Desktop Genetics Company
Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Investors
(Reupload).png)
.png)
Technology:
Biologics
Industry:
Early Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2012-01-01
Employees Number:
11-50
Funding Status:
Undisclosed
Investors Number:
14
Total Funding:
8571521
Estimated Revenue:
Less than $1M
Last Funding Date:
2019-11-11
Last Funding Type:
Equity Crowdfunding
Register and Claim Ownership